Zhang Zhiqian, Assistant Professor of Medicine, Southern University of Science and Technology. His research interests include tumor molecular biology, tumor immunology, and epigenetics. In recent years, he has published more than 20 papers in international mainstream SCI journals such as FASEB Journal, Cancer Research, Breast Cancer Research, Molecular Cancer, Journal of Immunology, Molecular and Cellular Biology, Frontiers in Immunology and Journal of Genetics and Genomics. The article cited more than 700 times. He has been invited to do academic or topical lectures at domestic academic conferences.

Research

Teaching

Work experience

March 2012 to June 2014: Visiting students, Winship Cancer Institute, Emory University, USA.

July 2014 to July 2015: Postdoctoral, MD Anderson Cancer Research Center, USA.

July 2015 to April 2017: Assistant Researcher, State Key Laboratory of Medicinal Chemistry Biology, Nankai University.

May 2017, October 2018: Deputy General Manager, Executive Director and Technical Director of Tianjin Kemei Biotechnology Co., Ltd.

November 2018-present: Assistant Professor of Research, School of Medicine, Southern University of Science and Technology.

Education background
September 2004 to June 2008: Bachelor of Science in Biological Sciences, School of Life Sciences, Nankai University, Tianjin.
September 2008 to June 2014: Ph.D. in Genetics, School of Life Sciences, Nankai University, Tianjin.

Selected publications

1. Tao, F., Tian, X., Ruan, S., Shen, M. and Zhang, Z. miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma. FASEB JOURNAL 2018; fj201800495RR .
2. Tao F, Tian X, Lu M and Zhang Z. A novel lncRNA, Lnc-OC1, promotes ovarian cancer cell proliferation and migration by sponging miR-34a and miR-34c. J Genet Genomics 2018; 45: 137-145.
3. Zhang, Z., Zhu, Z., Zhang, B., Li, W., Li, X., Wu, X., Wang, L., Fu, L., Fu, L., and Dong, JT (2014) Frequent mutation of rs13281615 and its association with PVT1 expression and cell proliferation in breast cancer. J Genet Genomics 41, 187-195.
4. Zhang, Z., Zhang, B., Li, W., Fu, L., Fu, L., Zhu, Z., and Dong, JT (2011) Epigenetic Silencing of miR-203 Upregulates SNAI2 and Contributes to The Invasiveness of Malignant Breast Cancer Cells. Genes Cancer 2, 782-791.
5. Huang, Y.#, Qi, H.#, Zhang, Z.#, Wang, E.#, Yun, H., Yan, H., Su, X., Liu, Y., Tang, Z. , Gao, Y., Shang, W., Zhou, J., Wang, T., Che, Y., Zhang, Y., and Yang, R. (2017) Gut REG3gamma-Associated Lactobacillus Induces Anti-inflammatory Macrophages to Maintain Adipose Tissue Homeostasis. Front Immunol 8, 1063.
6. Xin, J.#, Zhang, Z.#, Su, X., Wang, L., Zhang, Y., and Yang, R. (2017) Epigenetic Component p66a Modulates Myeloid-Derived Suppressor Cells by Modifying STAT3. J Immunol 198, 2712-2720.